S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Santhera Pharmaceuticals Holding AG
SIX:SANN
Price:
12.2
CHF
-3.94%
Market Closed
Market Cap:
129.6m
CHF
Section:
Wall Street
Price Targets
Wall Street
Price Targets
SANN Price Targets Summary
Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG
Wall Street analysts forecast SANN stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for SANN is 30.6 CHF with a low forecast of 30.3 CHF and a high forecast of 31.5 CHF.
Lowest
Price Target
30.3
CHF
148% Upside
Average
Price Target
30.6
CHF
151% Upside
Highest
Price Target
31.5
CHF
158% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SANN's stock price target?
Price Target
30.6
CHF
30.6
CHF
According to Wall Street analysts, the average 1-year price target for SANN is 30.6 CHF with a low forecast of 30.3 CHF and a high forecast of 31.5 CHF.
What is Santhera Pharmaceuticals Holding AG's Revenue forecast?
Projected CAGR
60%
60%
For the last 8 years the compound annual growth rate for Santhera Pharmaceuticals Holding AG's revenue is 9%. The projected CAGR for the next 3 years is 60%.
You don't have any saved screeners yet
